The Pre-Filled Syringes Market Expected To Reach $6 Billion By 2020: Opportunity Trends And Forecast 2015-2030 Business

The Pre-Filled Syringes Market Expected To Reach $6 Billion By 2020: Opportunity Trends And Forecast 2015-2030

BY swapnil devale • February 16, 2016
swapnil devale

swapnil devale

  • 258 Articles
  • 506 Views
  • Joined February 12, 2016

Market Research Growth And Trends On "The Pre-Filled Syringes Market: 2015-2030"

A pre-filled syringe is a medical syringe that comes pre-filled with a specific dosage of medication. Representing one of the fastest growing segments of the injectable drug delivery ecosystem, pre-filled syringes offer significant benefits over the traditional ‘vial and syringe’ format, by increasing dosing accuracy, safety and convenience. 

In addition, pre-filled syringes also offer a variety of economic benefits to pharmaceutical companies including a reduction in drug overfill and waste, which increases the saleable yield of the API (Active Pharmaceutical Ingredient).

SNS Research estimates that the market for pre-filled syringes will account for over $3.2 Billion in revenue by the end of 2015. Despite challenges relating to drug stability, manufacturing and competition from other drug delivery technologies, the market is poised for significant growth in the coming years.  Expected to grow at a CAGR of 13% between 2015 and 2020, the market will account for nearly $6 Billion in revenue by the end of 2020.

Download The sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/232277

The “Pre-Filled Syringes Market: 2015 – 2030 – Opportunities, Challenges, Strategies & Forecasts” report presents an in-depth assessment of the pre-filled syringes ecosystem including technology, market drivers, challenges, investment potential, leading therapies, use cases, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents market size forecasts for pre-filled syringe unit sales from 2015 through to 2030. The forecasts are further segmented for 4 horizontal submarkets, 10 drug classes, 5 regions and 13 leading countries.

The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.

Key Findings:

The report has the following key findings:

SNS Research estimates that the market for pre-filled syringes will account for over $3.2 Billion in revenue by the end of 2015. Expected to grow at a CAGR of 13% between 2015 and 2020, the market will account for nearly $6 Billion in revenue by the end of 2020

Many pre-filled syringe manufacturers now also offer integrated automatic needle shielding or retractable needle options

While glass continues to remain the gold standard for pre-filled syringes, the proportion of plastic based pre-filled syringes is expected to increase by 5% between 2015 and 2020, due to concerns of glass breakage and plunger failure

A number of pre-filled syringe manufacturers have developed dual and multi chambered syringes, to cater for drugs that must be reconstituted at the point of delivery

Pre-filled pen systems and auto-injectors will grow at a CAGR of more than 20% over the next five years

Browse More Published Reports @ http://www.marketresearchreports.biz/publisher/45

Topics Covered:

The report covers the following topics:

Pre-filled syringes ecosystem

Market drivers and barriers

Technology, safety mechanisms and key trends

Pen systems and auto-injectors

Industry roadmap and value chain

Analysis of leading drug classes and pre-filled syringe therapies

Profiles and strategies of 55 leading ecosystem players, including manufacturers and pharmaceutical giants

Strategic recommendations for ecosystem players

Market analysis and forecasts from 2015 till 2030

Historical Revenue & Forecast Segmentation:

Market forecasts are provided for each of the following submarkets and their subcategories:

Material

Glass

Plastic

Injector Type

Conventional

Pen Systems & Auto-Injectors

Drug Class

MAbs (Monoclonal Antibodies)

Insulins

Erythropoietins

Interferons

G-CSF Agents

Anticoagulants & Recombinant Coagulation Factors

Biosimilars & Follow-on Protein Products

Vaccines

Growth Hormones

Others

Browse More Drug Delivery Market Research Reports @ http://www.marketresearchreports.biz/category/62

Regional Markets

Asia Pacific

Europe

Middle East & Africa

North America

Latin & Central America

Country Markets

Brazil

Canada

China

France

Germany

India

Italy

Japan

Korea

Russia

Spain

UK

USA

Key Questions Answered:

The report provides answers to the following key questions:

How big is the pre-filled syringes opportunity?

What factors are influencing its growth?

How is the ecosystem evolving by segment and region?

What will the market size be in 2020 and at what rate will it grow?

What trends, challenges and barriers are influencing its growth?

Who are the key market players and what are their strategies?

Which countries and submarkets will see the highest percentage of growth?

How will patent expiries of biologics impact the pre-filled syringes market?

What are the future prospects of multi chamber pre-filled syringes?

How does regulation impact pre-filled syringes?

What strategies should pre-filled syringe manufacturers adopt to remain competitive?

List of Companies Mentioned:

The following companies and organizations have been reviewed, discussed or mentioned in the report:

Abbott Laboratories

Amgen

AMRI (Albany Molecular Research, Inc.)

Aptar Stelmi

AptarGroup

Artemes Technologies

AstraZeneca

Battelle

Baxter International (Baxter BioPharma Solutions)

BD (Becton, Dickinson and Company)

Bespak

Biocon

Bioneer

Boehringer Ingelheim

BSM (Bristol-Myers Squibb)

Catalent Pharma Solutions

Chugai Pharmaceuticals

Coldstream Laboratories

Consort Medical

Covidien

Daiko Seiko

Dätwyler Holding

Elcam Medical

Eli Lilly and Company

FDA (U.S. Food and Drug Administration)

Fischer Clinical Services

Genentech

Gerresheimer

GSK (GlaxoSmithKline)

Haselmeier

Hospira

Hyaluron

Janssen Biotech

Janssen Research & Development

Johnson & Johnson

Laboratorios Farmacéuticos ROVI

Liebmann Group

LTI (Lyophilization Technology, Inc.)

Medilet

MedPro Safety Products

Medtronic

Merck and Co.

MGlas

Nipro Corporation

Novartis International

Novo Nordisk

Ompi (Stevanato Group)

Owen Mumford

PA Consulting

Pfanstiehl

Pfizer

Revolutions Medical Corporation

Roche Holding (F. Hoffmann-La Roche)

Roselabs

Safety Syringes

Sanofi

Schott

SHL Group

Takeda Pharmaceutical Company

Terumo Corporation

Terumo Europe 

Teva Pharmaceutical Industries

Unilife Corporation

Ventana

Vetter Pharma (Vetter Pharma-Fertigung GmbH & Co. KG)

Weigao Group (Shandong Weigao Group Medical Polymer Co.)

West Pharmaceutical Services

Ypsomed Holding

Yukon Medical

Zogenix




About InwebArticles

InwebArticles brings to you creativity at its best. Expert writers and InWeb publishers have brought together a podium where only useful, genuine and media-enriched pages are posted.
More..

Contact us




Newsletter

Subscribe to newsletter